SCHEMBL5598124

SCHEMBL5598124

Oc1cccc2cc3ccccc3c(O)c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.72
ALDH1A1 P00352 3/20 0.72
KMT2A Q03164 3/20 0.72
DNMT1 P26358 1/20 0.72
CACNA1B Q00975 1/20 0.72
APBA1 Q02410 1/20 0.72
MCL1 Q07820 1/20 0.72
APOBEC3G Q9HC16 1/20 0.72
CYP1A2 P05177 3/20 0.52
MAOA P21397 2/20 0.48
ERBB2 P04626 1/20 0.48
FYN P06241 1/20 0.48
ACHE P22303 1/20 0.48
AHR P35869 1/20 0.48
PTPN22 Q9Y2R2 1/20 0.48
TRPM4 Q8TD43 1/20 0.48
NQO2 P16083 1/20 0.47
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
MAPT P10636 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30066036 1.00 MEN1 (0.72) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL31035951 1.00 MEN1 (0.72) MEN1ALDH1A1KMT2ADNMT1CACNA1B
Methane SCHEMBL7938130 0.98 MEN1 (0.69) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL3198 0.84 ALDH1A1 (1.00) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL9742451 0.84 ALDH1A1 (0.73) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL7911783 0.83 ALDH1A1 (0.65) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL26248752 0.82 MEN1 (0.64) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL11107827 0.82 PTPN22 (0.63) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL27520184 0.81 PTPN22 (0.56) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL3320154 0.80 ALDH1A1 (0.91) MEN1ALDH1A1KMT2ADNMT1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1154778-A2 PHARMACEUTICAL PREPARATION CONTAINING DITHRANOL Esparma GmbH (DE) 2001-11-21 EP claimed
WO-2000050018-A2 PHARMACEUTICAL PREPARATION CONTAINING DITHRANOL ESPARMA GMBH (DE) 2000-08-31 WO claimed
US-20260020430-A1 COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR, QUANTUM DOT LIGHT-EMITTING DIODE TCL TECHNOLOGY GROUP CORPORATION (CN) 2026-01-15 US disclosed
US-20250101182-A1 POLY(ESTER-IMIDE) POLYMERS AND USES THEREOF SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2025-03-27 US disclosed
CN-117757462-A Composite material, preparation method thereof and quantum dot light emitting diode TCL科技集团股份有限公司 2024-03-26 CN disclosed
WO-2024056004-A1 COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR, AND QUANTUN DOT LIGHT-EMITTING DIODE TCL科技集团股份有限公司 2024-03-21 WO disclosed
WO-2023223924-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE DIC株式会社 2023-11-23 WO disclosed
WO-2023223923-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT DIC株式会社 2023-11-23 WO disclosed
US-20230296982-A1 POLYMER, COMPOSITION, METHOD FOR PRODUCING POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, RESIST COMPOSITION, RADIATION-SENSITIVE COMPOSITION, COMPOSITION FOR UNDERLAYER FILM FORMATION FOR LITHOGRAPHY, RESIST PATTERN FORMATION METHOD, METHOD FOR PRODUCING UNDERLAYER FILM FOR LITHOGRAPHY, CIRCUIT PATTERN FORMATION METHOD, AND COMPOSITION FOR OPTICAL MEMBER FORMATION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-21 US disclosed
WO-2023275221-A1 METAL COMPLEXES FOR OPTICAL AND MICROELECTRONIC APPLICATIONS MERCK PATENT GMBH (DE) 2023-01-05 WO disclosed
CN-104903363-B Monomer, liquid-crystal composition, the manufacture method of liquid crystal display device and liquid crystal display device 夏普株式会社 2018-05-04 CN disclosed
US-5340931-A Chemical intermediates for allyl or vinyl ether polymers NIPPON PAINT CO., LTD. (JP) 1994-08-23 US disclosed
EP-0457334-B1 Carbonates of acetylenic alcohols NIPPON PAINT CO LTD (JP) 1994-08-10 EP disclosed
CN-1023324-C Method of preventing polymer-scale formation SHINETSU CHEMICAL CO (JP) 1993-12-29 CN disclosed
US-5258542-A Carbonates of acetylenic alcohols NIPPON PAINT CO., LTD. (JP) 1993-11-02 US disclosed
US-5194653-A Useful in making heat resistant liquid crystalline polymers NIPPON PAINT COMPANY, LIMITED (JP) 1993-03-16 US disclosed
EP-0457334-A1 Carbonates of acetylenic alcohols NIPPON PAINT CO., LTD. (JP) 1991-11-21 EP disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
EP-0333445-A2 Aromatic allene compounds and preparation thereof NIPPON PAINT CO., LTD. (JP) 1989-09-20 EP disclosed
US-4657838-A DEVELOPMENT OF ELECTROSTATIC IMAGES CANON KABUSHIKI KAISHA (JP) 1987-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260020430-A1 COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR, QUANTUM DOT LIGHT-EMITTING DIODE WEE1, WEE2, CTNNA1 MEN1 3323/4885ALDH1A1 347/4885KMT2A 1619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.